You are here

Article info

Article menu
Download PDFPDF
Multiple sclerosis
Original research
Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study

Authors

  • Mathias Due Buron Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDanish Multiple Sclerosis Registry, Rigshospitalet, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Tomas Kalincik CORe, Department of Medicine, University of Melbourne, Melbourne, Victoria, AustraliaMelbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Finn Sellebjerg Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Per Soelberg Sørensen Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Melinda Magyari Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDanish Multiple Sclerosis Registry, Rigshospitalet, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mathias Due Buron, Department of Neurology, Danish Multiple Sclerosis Center, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark; mathias.buron{at}regionh.dk
View Full Text

Citation

Buron MD, Kalincik T, Sellebjerg F, et al
Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study
Journal of Neurology, Neurosurgery & Psychiatry 2021;92:556-562.

Publication history

  • Received August 12, 2020
  • Revised December 5, 2020
  • Accepted December 14, 2020
  • First published January 12, 2021.
Online issue publication 
April 15, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.